Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ELIZABATH REMY GEORGE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1972067379
CMS profile
10491754
Location
SHERMAN, TX

General Payments · PY2021–2024

$3,818.45

  • Reported across 197 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,053.36

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $946.86 52
Education $106.50 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $368.68 19
Neurocrine BioSciences, Inc. $260.63 12
Janssen Pharmaceuticals, Inc $162.27 9
ITI, Inc. $106.48 5
Indivior Inc. $62.22 3
Otsuka America Pharmaceutical, Inc. $37.67 2
ABBVIE INC. $32.95 2
Lundbeck LLC $22.46 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,059.09 60
PY2022 $841.35 32
PY2023 $864.65 52
PY2024 $1,053.36 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.28 03/04/2024 Food and Beverage Undisputed 01/23/2026 1107162585 CMS
ABBVIE INC. $19.67 07/08/2024 Food and Beverage Undisputed 01/23/2026 1107162587 CMS
Indivior Inc. $24.18 01/29/2024 Food and Beverage Undisputed 01/23/2026 1144553358 CMS
Indivior Inc. $13.73 04/12/2024 Food and Beverage Undisputed 01/23/2026 1144553360 CMS
Indivior Inc. $24.31 05/03/2024 Food and Beverage Undisputed 01/23/2026 1144553362 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.07 01/17/2024 Food and Beverage Undisputed 01/23/2026 1143460962 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.30 05/08/2024 Food and Beverage Undisputed 01/23/2026 1143460966 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.84 07/10/2024 Food and Beverage Undisputed 01/23/2026 1143460970 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.05 10/08/2024 Food and Beverage Undisputed 01/23/2026 1143460974 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.22 12/04/2024 Food and Beverage Undisputed 01/23/2026 1143460977 CMS
Janssen Pharmaceuticals, Inc $21.58 02/14/2024 Food and Beverage Undisputed 01/23/2026 1078200847 CMS
Janssen Pharmaceuticals, Inc $16.15 03/14/2024 Food and Beverage Undisputed 01/23/2026 1078200419 CMS
Janssen Pharmaceuticals, Inc $19.71 03/28/2024 Food and Beverage Undisputed 01/23/2026 1078200733 CMS
Janssen Pharmaceuticals, Inc $11.72 04/11/2024 Food and Beverage Undisputed 01/23/2026 1078200525 CMS
Janssen Pharmaceuticals, Inc $20.88 07/17/2024 Food and Beverage Undisputed 01/23/2026 1078200823 CMS
Janssen Pharmaceuticals, Inc $16.59 09/04/2024 Food and Beverage Undisputed 01/23/2026 1078200233 CMS
Janssen Pharmaceuticals, Inc $17.31 09/11/2024 Food and Beverage Undisputed 01/23/2026 1078200273 CMS
Janssen Pharmaceuticals, Inc $14.81 10/02/2024 Food and Beverage Undisputed 01/23/2026 1078200187 CMS
Janssen Pharmaceuticals, Inc $23.52 11/20/2024 Food and Beverage Undisputed 01/23/2026 1078199843 CMS
Lundbeck LLC $22.46 03/06/2024 Food and Beverage Undisputed 01/23/2026 1146025709 CMS
Neurocrine Biosciences, Inc. $28.87 01/24/2024 Food and Beverage Undisputed 01/23/2026 1150942501 CMS
Neurocrine Biosciences, Inc. $6.29 02/01/2024 Food and Beverage Undisputed 01/23/2026 1151020876 CMS
Neurocrine Biosciences, Inc. $7.49 03/02/2024 Food and Beverage Undisputed 01/23/2026 1151018268 CMS
Neurocrine Biosciences, Inc. $32.42 03/07/2024 Food and Beverage Undisputed 01/23/2026 1150935244 CMS
Neurocrine Biosciences, Inc. $31.08 03/26/2024 Food and Beverage Undisputed 01/23/2026 1150937456 CMS
Neurocrine Biosciences, Inc. $6.19 04/04/2024 Food and Beverage Undisputed 01/23/2026 1151021168 CMS
Neurocrine Biosciences, Inc. $28.11 05/14/2024 Food and Beverage Undisputed 01/23/2026 1150944629 CMS
Neurocrine Biosciences, Inc. $4.95 05/23/2024 Food and Beverage Undisputed 01/23/2026 1151023682 CMS
Neurocrine Biosciences, Inc. $31.02 06/25/2024 Food and Beverage Undisputed 01/23/2026 1150937544 CMS
Neurocrine Biosciences, Inc. $32.98 07/29/2024 Food and Beverage Undisputed 01/23/2026 1150934478 CMS
Neurocrine Biosciences, Inc. $25.11 08/26/2024 Food and Beverage Undisputed 01/23/2026 1150954687 CMS
Neurocrine Biosciences, Inc. $26.12 10/07/2024 Food and Beverage Undisputed 01/23/2026 1150951133 CMS
Otsuka America Pharmaceutical, Inc. $13.10 08/21/2024 Food and Beverage Undisputed 01/23/2026 1119078678 CMS
Otsuka America Pharmaceutical, Inc. $24.57 09/05/2024 Food and Beverage Undisputed 01/23/2026 1119078680 CMS
Teva Pharmaceuticals USA, Inc. $22.17 01/22/2024 Food and Beverage Undisputed 01/23/2026 1151645701 CMS
Teva Pharmaceuticals USA, Inc. $25.11 03/13/2024 Food and Beverage Undisputed 01/23/2026 1151645719 CMS
Teva Pharmaceuticals USA, Inc. $9.21 04/08/2024 Food and Beverage Undisputed 01/23/2026 1151645733 CMS
Teva Pharmaceuticals USA, Inc. $0.56 04/17/2024 Food and Beverage Undisputed 01/23/2026 1151645735 CMS
Teva Pharmaceuticals USA, Inc. $25.27 04/17/2024 Food and Beverage Undisputed 01/23/2026 1151645737 CMS
Teva Pharmaceuticals USA, Inc. $1.03 04/24/2024 Food and Beverage Undisputed 01/23/2026 1151645751 CMS
Teva Pharmaceuticals USA, Inc. $29.94 04/24/2024 Food and Beverage Undisputed 01/23/2026 1151645753 CMS
Teva Pharmaceuticals USA, Inc. $7.91 04/30/2024 Food and Beverage Undisputed 01/23/2026 1151645755 CMS
Teva Pharmaceuticals USA, Inc. $0.61 05/06/2024 Food and Beverage Undisputed 01/23/2026 1151645757 CMS
Teva Pharmaceuticals USA, Inc. $19.10 05/06/2024 Food and Beverage Undisputed 01/23/2026 1151645759 CMS
Teva Pharmaceuticals USA, Inc. $106.50 05/06/2024 Education Undisputed 01/23/2026 1151645819 CMS
Teva Pharmaceuticals USA, Inc. $5.87 05/30/2024 Food and Beverage Undisputed 01/23/2026 1151645761 CMS
Teva Pharmaceuticals USA, Inc. $36.43 06/04/2024 Food and Beverage Undisputed 01/23/2026 1151645783 CMS
Teva Pharmaceuticals USA, Inc. $21.17 06/13/2024 Food and Beverage Undisputed 01/23/2026 1151645805 CMS
Teva Pharmaceuticals USA, Inc. $11.32 08/28/2024 Food and Beverage Undisputed 01/23/2026 1151645807 CMS
Teva Pharmaceuticals USA, Inc. $5.78 10/10/2024 Food and Beverage Undisputed 01/23/2026 1151645829 CMS
Teva Pharmaceuticals USA, Inc. $7.94 10/16/2024 Food and Beverage Undisputed 01/23/2026 1151645831 CMS
Teva Pharmaceuticals USA, Inc. $19.37 10/30/2024 Food and Beverage Undisputed 01/23/2026 1151645833 CMS
Teva Pharmaceuticals USA, Inc. $13.39 11/18/2024 Food and Beverage Undisputed 01/23/2026 1151645841 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.